Key Capital Corporation
KCPC
Other OTC0.00
USD
- -
- -
ISIN
US4930742071
CUSIP
493074207
Return %
Stock
S&P500
1Y
0.00
26.53
3Y
0.00
76.60
5Y
0.00
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Jennifer Reilly
- Sector
- Financial Services
- Industry
- Financial - Conglomerates
- Address
- 244 Fifth Avenue New York City United States of America
- IPO Date
- May 24, 2023
- Website
- keycapitalcorp.com
- Similar Companies
- Business
- Key Capital Corporation (KCPC), a development stage financial conglomerate founded in 1996 and headquartered at 244 Fifth Avenue, Suite P279, New York, New York 10001, United States, specializes in structured financing, streaming agreements, and equity funding for mining and energy projects worldwide. The company arranges plant and infrastructure financing for mid-market mining and energy initiatives advancing to commercial production; provides streaming deals granting life-of-mine interests in gold, silver, base metals, or energy products; funds resource projects via an online lending platform; and, through its subsidiary GeoGlobal Resources, Inc., pursues oil and gas exploration and production in India's Cambay Basin and Krishna-Godavari Basin. It operates across diversified sectors including mining and energy, fintech, and life sciences, targeting institutional clients and project developers in global markets. Originally incorporated in Georgia as ABCOR Computer Services, Inc., the company underwent name changes to Elite Computer Services, Inc. in 1996 and to Key Capital Corporation in 1998, with a registration to conduct business in Arizona noted in 2012; no major acquisitions, funding rounds, partnerships, or new product launches have been publicly reported in the last 1-2 years.
Key Capital Offers to Help India COVID Crisis with Major Aid Potential via its 24/7 Immune Supplement
Key Capital HAP-V+ Immune Supplement Reported Effective Against COVID-19, and Colds and Flu
Key Capital Launches Unique Natural Mental Health Supplement - MaxCellLife MIND
Key Capital Launches MaxCellLife.com to Market Unique Supplement and Skincare Products
Key Capital to Focus on Oral Pill Cancer Treatment Success
Key Capital Leads Oral Pill Vaccines Race with Immunitor Partnering and Strong Patenting
Key Capital COVID-19 Oral Pill Vaccine Records 90% Reduction in Virus Infectivity in Early Study
Key Capital Advises Urgent Global Need For COVID-19 Oral Pill Therapeutic Vaccine